# STIMUFEND
> **BLA761173** · Biologics License Application · Sponsor: FRESENIUS KABI USA · Approved 2022-09-01
## Drug
- **FDA Application Number:** BLA761173
- **Application type:** Biologics License Application
- **Brand name:** STIMUFEND
- **Generic name:** PEGFLILGRASTIM-FPGK
- **Active ingredients:** PEGFILGRASTIM-FPGK
- **Dosage form:** SOLUTION
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2022-09-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761173)
---
*AI Analytics · CC0 1.0*